ICAM‐1 enables immune cells to effectively extravasate into tissues, so its upregulation is expected to facilitate the observed influx of inflammatory monocytes, neutrophils and other immune cells into the lungs of severe COVID‐19 patients.60 The gene discussed is ICAM1; the disease is COVID-19.